GATA6 has been suggested to be oncogenic in multiple cancers and pre-cancerous lesions, including Barrett’s esophagus, gastric cancer, pancreatic cancer, and colon cancer [20]. This evidence concerns the gene GATA6 and esophageal adenocarcinoma.